Safonova, Ekaterina
Yawn, Barbara P.
Welte, Tobias
Wang, Chengbin
Article History
Received: 9 March 2022
Accepted: 23 December 2022
First Online: 28 January 2023
Declarations
:
: Not applicable.
: Not applicable.
: ES and CW are employees of GSK; ES is a shareholder. BY reports grants and personal fees (for consultation and participation in advisory boards) from GSK, grants from BI, grants from AZ, andgrants from TEVA, grants from Pulmonx. Outside the work on this manuscript. TW has received fees from GSK for lectures and participation in advisory boards, but not for work on this manuscript.